Allogenic hematopoietic cell transplantation (allo-HCT) involves transferring healthy donor stem cells to recipients with conditions such as blood cancer, bone marrow failure, or certain genetic blood disorders. Acute graft-versus-host disease (aGVHD) is a common complication, where the donor’s immune cells attack the recipient’s tissues. Allogenic hematopoietic cell transplantation (allo-HCT) involves transferring healthy donor stem cells to recipients with conditions such as blood cancer, bone marrow failure, or certain genetic blood disorders. Acute graft-versus-host disease (aGVHD) is a common complication, where the donor’s immune cells attack the recipient’s tissues. Cell & Microbiology Molecular & Computational biology Phys.org – latest science and technology news stories
Phage-derived enzyme targets E. faecalis biofilms to mitigate acute graft-versus-host disease
